Differential effects of adjuvant EGFR tyrosine kinase inhibitors in patients with different stages of non-small-cell lung cancer after radical resection: an updated meta-analysis

PURPOSE: A survival improvement was achieved with adjuvant chemotherapy in non-small-cell lung cancer (NSCLC) patients, but its differential effects among patients with different stages remained controversial. This study aimed to compare the beneficial effects of adjuvant tyrosine kinase inhibitor (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Di, Wang, Zhizhi, Liu, Xiguang, Feng, Siyang, Dong, Xiaoying, Shi, Xiaoshun, Wang, He, Wu, Hua, Xiong, Gang, Wang, Haofei, Cai, Kaican
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450185/
https://www.ncbi.nlm.nih.gov/pubmed/31037035
http://dx.doi.org/10.2147/CMAR.S187940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450185/
https://www.ncbi.nlm.nih.gov/pubmed/31037035
http://dx.doi.org/10.2147/CMAR.S187940

Ejemplares similares